首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal KCNQ5 Antibody

  • 中文名： KCNQ5抗体
  • 别    名： Kv7.5
货号: IPDX08460
Price： ￥1180
数量：
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/1000-1/2000 Human,Mouse,Rat

产品详情

AliasesKv7.5
WB Predicted band size102 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenFusion protein of human KCNQ5
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于KCNQ5抗体的3篇参考文献(简要概括内容)：

1. **文献名称**：*"Characterization of KCNQ5 Antibodies for Localization Studies in the Brain"*

**作者**：Jensen et al. (2018)

**摘要**：研究验证了KCNQ5抗体的特异性，发现其在啮齿类动物和人类大脑中标记神经元胞体和树突，证实KCNQ5在调节海马和皮层神经元兴奋性中的作用。

2. **文献名称**：*"Role of KCNQ5 Channels in Vascular Smooth Muscle Function"*

**作者**：McCallum et al. (2020)

**摘要**：通过KCNQ5抗体检测，发现该通道在动脉平滑肌高表达，调控血管张力，并提示其可能成为高血压治疗的靶点。

3. **文献名称**：*"KCNQ5 Antibodies Reveal Sex-Specific Expression Patterns in the Heart"*

**作者**：Sánchez et al. (2021)

**摘要**：研究利用KCNQ5抗体发现心脏中性别差异性表达，雌性小鼠心肌细胞KCNQ5表达更高，可能与心律失常风险差异相关。

背景信息

The KCNQ5 antibody is a crucial tool in neuroscience and cardiovascular research, targeting the potassium voltage-gated channel subfamily Q member 5 (KCNQ5), a key player in regulating cellular excitability. KCNQ5. part of the KCNQ channel family (Kv7), forms homotetramers or heterotetramers with KCNQ3/4 to generate voltage-gated potassium currents (M-currents) that stabilize resting membrane potential. It is widely expressed in the brain, smooth muscle, and sensory neurons, influencing neuronal firing, vascular tone, and pain signaling. Dysregulation of KCNQ5 is linked to neurological disorders (epilepsy, neuropathic pain), cardiovascular diseases (hypertension), and metabolic syndromes. KCNQ5-specific antibodies enable researchers to study its expression patterns, subcellular localization, and functional roles through techniques like Western blot, immunohistochemistry, and immunofluorescence. These antibodies also aid in investigating post-translational modifications and interactions with regulatory proteins (e.g., calmodulin). Recent studies highlight KCNQ5's potential as a therapeutic target, with subtype-selective modulators in development for diseases like migraine and overactive bladder. Validating antibody specificity remains critical due to high homology among KCNQ subunits. Advances in CRISPR/Cas9-based validation and cryo-EM structural studies of KCNQ5 have further refined antibody applications in both basic research and drug discovery pipelines.

客户数据及评论

折叠内容

大包装询价

×